Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
AIxCrypto Holdings ( (AIXC) ) has provided an update.
In its inaugural full-year report as AIxCrypto Holdings, the company detailed its 2025 transformation from a biopharma business into an AI and blockchain infrastructure player, backed by a $41 million PIPE financing completed in September 2025 and a November 20, 2025 rebrand and Nasdaq relisting under the AIXC ticker. Management installed a new leadership team, established Nasdaq-level governance and compliance structures, and ended 2025 with about $31 million in assets, including $19 million in cash and a growing $10 million digital asset treasury.
Operationally, AIxCrypto advanced initial build-out of its AI Agent and Embodied AI ecosystem across application, protocol-device, and infrastructure layers, launched AIxC Hub in January 2026 with millions of registered wallets, and formed partnerships with BitMart, Sei Foundation, and Pinnacle Real Estate Group to expand real-world crypto payments and RWA tokenization. The company also initiated its RWA strategy, deploying $10 million into Faraday Future stock for prospective equity tokenization and forging a real estate loan tokenization venture, positioning itself for 2026 growth in AI-enabled digital asset infrastructure despite elevated 2025 operating cash burn versus 2024.
Spark’s Take on AIXC Stock
According to Spark, TipRanks’ AI Analyst, AIXC is a Underperform.
Qualigen Therapeutics’ overall stock score is low due to significant financial challenges, including declining revenue, substantial losses, and financial instability. The bearish technical analysis further dampens the outlook. However, recent corporate events like strategic investments and leadership changes provide a slight positive outlook on future potential improvements.
To see Spark’s full report on AIXC stock, click here.
More about AIxCrypto Holdings
AIxCrypto Holdings, Inc., formerly clinical-stage biopharmaceutical firm Qualigen Therapeutics, has repositioned itself as an AI and blockchain-enabled digital infrastructure company. Now listed on the Nasdaq Capital Market under ticker AIXC, it focuses on Real World Asset tokenization, AI agents, and Embodied AI blockchain ecosystems that link Web2 and Web3 and support autonomous robots, smart vehicles, and drones.
The company is building a three-layer ecosystem spanning infrastructure, protocol-device, and application layers to power what it calls a silicon-based economy. Its primary user gateway, AIxC Hub, underpins this strategy by aggregating behavioral data from millions of registered wallets and daily active participants, which is used to train the firm’s Embodied AI models and support future digital asset and AI-driven services.
Average Trading Volume: 72,252
Technical Sentiment Signal: Sell
Current Market Cap: $6.09M
See more insights into AIXC stock on TipRanks’ Stock Analysis page.